SCHEMBL1680473

SCHEMBL1680473

O=C(O)c1cccc(Cl)c1OO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
ALDH1A1 P00352 5/20 0.57
KMT2A Q03164 3/20 0.48
PBRM1 Q86U86 1/20 0.45
KDM4E B2RXH2 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 2/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
MEN1 O00255 2/20 0.44
LMNA P02545 2/20 0.44
TP53 P04637 1/20 0.44
HTT P42858 1/20 0.44
USP2 O75604 1/20 0.44
MT-CO2 P00403 1/20 0.44
TTR P02766 1/20 0.44
PLA2G1B P04054 1/20 0.44
CYP1A2 P05177 1/20 0.44
PGR P06401 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL73044 0.84 TSHR (0.59) TSHRALDH1A1KMT2APBRM1KDM4E
SCHEMBL8406918 0.83 ALDH1A1 (0.57) TSHRALDH1A1KMT2APBRM1HPGD
SCHEMBL28288294 0.82 TSHR (0.57) TSHRALDH1A1KMT2APBRM1KDM4E
SCHEMBL28022554 0.82 TSHR (0.57) TSHRALDH1A1KMT2APBRM1KDM4E
SCHEMBL30410031 0.82 TSHR (0.57) TSHRALDH1A1KMT2APBRM1KDM4E
SCHEMBL28079050 0.82 TSHR (0.57) TSHRALDH1A1KMT2APBRM1KDM4E
SCHEMBL477714 0.82 TSHR (0.57) TSHRALDH1A1KMT2APBRM1KDM4E
SCHEMBL28101443 0.81 TSHR (0.47) TSHRALDH1A1KMT2APBRM1KDM4E
Hydrochloric Acid SCHEMBL11052815 0.81 TSHR (0.55) TSHRALDH1A1KMT2APBRM1KDM4E
Ammonia Solution, Strong SCHEMBL27869906 0.81 TSHR (0.55) TSHRALDH1A1KMT2APBRM1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND NAKAMOTO KAZUTAKA 2011-08-11 US disclosed
US-7932272-B2 Antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-04-26 US disclosed
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-09-10 US disclosed
WO-2009103007-A2 STEROID HORMONE RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 2009-08-20 WO disclosed
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2007-05-10 US disclosed
EP-1782811-A1 NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2007-05-09 EP disclosed
EP-1669348-A1 NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND Eisai Co., Ltd. (JP) 2006-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195999-A1 NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND ERG28, CYP51A1, XPO1 TSHR 3875/4885ALDH1A1 1677/4885KMT2A 3747/4885
US-20090227799-A1 Novel Antimalarial Agent Containing Heterocyclic Compound XPO1, THPO, G6PD TSHR 3836/4885ALDH1A1 1926/4885KMT2A 2620/4885
US-20070105943-A1 Novel antifungal agent containing heterocyclic compound ERG28, DPM1, CYP51A1 TSHR 3952/4885ALDH1A1 1459/4885KMT2A 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.